US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist

21.550
-0.240-1.10%

Trading Nov 19 09:48 ET

1.53BMarket Cap-7431P/E (TTM)

Nurix Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Aug 31, 2024

(Q2)May 31, 2024

(Q1)Feb 29, 2024

(FY)Nov 30, 2023

(Q4)Nov 30, 2023

(Q3)Aug 31, 2023

(Q2)May 31, 2023

(Q1)Feb 28, 2023

(FY)Nov 30, 2022

(Q4)Nov 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-2.54%-42.18M

-114.98%-39.71M

13.42%-41.95M

49.09%-81.37M

170.32%26.69M

11.18%-41.13M

43.89%-18.47M

-13.66%-48.45M

-89.42%-159.81M

-22.79%-37.96M

Net income from continuing operations

-32.38%-48.96M

-83.49%-44.55M

-1.93%-41.52M

20.19%-143.95M

10.19%-41.96M

19.09%-36.98M

46.53%-24.28M

4.23%-40.73M

-53.90%-180.36M

-23.91%-46.72M

Operating gains losses

----

6,077.78%556K

--12K

--448K

--40K

--56K

-92.97%9K

--0

Depreciation and amortization

22.52%4.15M

22.74%4.09M

22.26%3.89M

26.33%13.65M

23.71%3.76M

17.26%3.38M

26.63%3.33M

41.15%3.18M

77.70%10.81M

88.63%3.04M

Other non cash items

----

--201K

--0

Change In working capital

81.73%-2.7M

-12.04%-5.94M

45.14%-10.21M

205.78%20.12M

3,160.35%58.82M

-40.04%-14.78M

-319.02%-5.3M

-107.72%-18.62M

-308.73%-19.02M

-617.16%-1.92M

-Change in receivables

----

--0

--2M

----

354.45%6M

--0

-Change in prepaid assets

-127.93%-570K

-92.11%169K

171.79%1.17M

295.52%2.14M

-136.07%-417K

377.69%2.04M

214,300.00%2.14M

-7.46%-1.63M

79.90%-1.09M

93.31%1.16M

-Change in payables and accrued expense

103.92%7.13M

-49,468.42%-9.38M

140.94%2.66M

-37.42%4.74M

222.28%7.73M

481.06%3.5M

-99.76%19K

-90.15%-6.51M

-3.04%7.57M

-43.51%2.4M

-Change in other current liabilities

9.70%-1.68M

8.31%-1.63M

-11.98%-1.46M

-28.68%-6.27M

-11.41%-1.33M

-64.10%-1.86M

16.73%-1.78M

-219.12%-1.3M

5.31%-4.87M

56.05%-1.19M

-Change in other working capital

53.92%-7.59M

186.47%4.91M

-37.04%-12.59M

173.28%19.51M

1,287.02%50.84M

-77.21%-16.47M

39.81%-5.68M

-153.70%-9.18M

-286.86%-26.63M

-218.87%-4.28M

Cash from discontinued investing activities

Operating cash flow

-2.54%-42.18M

-114.98%-39.71M

13.42%-41.95M

49.09%-81.37M

170.32%26.69M

11.18%-41.13M

43.89%-18.47M

-13.66%-48.45M

-89.42%-159.81M

-22.79%-37.96M

Investing cash flow

Cash flow from continuing investing activities

-193.69%-21.34M

-399.03%-131.07M

121.02%35.51M

151.13%68.3M

-126.13%-14.37M

136.11%22.78M

1,019.85%43.83M

-59.86%16.07M

125.12%27.2M

250.61%55.01M

Net PPE purchase and sale

4.55%-2.35M

-79.35%-1.94M

-26.66%-2.88M

31.39%-8.4M

-0.78%-2.59M

28.06%-2.46M

61.28%-1.08M

34.42%-2.28M

-116.29%-12.24M

-197.56%-2.57M

Net investment purchase and sale

-175.26%-18.99M

-387.53%-129.13M

109.30%38.4M

94.47%76.7M

-120.47%-11.79M

142.30%25.23M

2,372.82%44.91M

-57.83%18.35M

138.45%39.44M

261.45%57.57M

Cash from discontinued investing activities

Investing cash flow

-193.69%-21.34M

-399.03%-131.07M

121.02%35.51M

151.13%68.3M

-126.13%-14.37M

136.11%22.78M

1,019.85%43.83M

-59.86%16.07M

125.12%27.2M

250.61%55.01M

Financing cash flow

Cash flow from continuing financing activities

2,586.03%45.77M

950,908.00%237.75M

9.66%1.62M

-97.25%3.22M

105.19%7K

-98.52%1.7M

-94.21%25K

-0.47%1.48M

-23.84%117.19M

-127.00%-135K

Net common stock issuance

--41.87M

----

--0

----

-87.08%19.4M

--0

Proceeds from stock option exercised by employees

128.76%3.9M

704.00%201K

9.66%1.62M

-96.71%3.22M

105.19%7K

-98.23%1.7M

-94.21%25K

-0.47%1.48M

2,525.29%97.79M

-127.00%-135K

Cash from discontinued financing activities

Financing cash flow

2,586.03%45.77M

950,908.00%237.75M

9.66%1.62M

-97.25%3.22M

105.19%7K

-98.52%1.7M

-94.21%25K

-0.47%1.48M

-23.84%117.19M

-127.00%-135K

Net cash flow

Beginning cash position

96.61%117.69M

47.12%50.71M

-15.06%55.53M

-19.08%65.38M

-10.84%43.21M

41.06%59.86M

-56.74%34.47M

-19.08%65.38M

-32.41%80.79M

-67.20%48.46M

Current changes in cash

-6.56%-17.75M

163.82%66.98M

84.42%-4.81M

36.13%-9.85M

-27.16%12.32M

-376.51%-16.65M

168.16%25.39M

-2,681.55%-30.9M

60.20%-15.42M

125.28%16.92M

End cash Position

131.33%99.95M

96.61%117.69M

47.12%50.71M

-15.06%55.53M

-10.84%43.21M

41.06%59.86M

-56.74%34.47M

-19.08%65.38M

Free cash flow

-2.14%-44.52M

-113.01%-41.64M

11.62%-44.84M

47.83%-89.77M

159.49%24.1M

12.34%-43.59M

45.25%-19.55M

-10.04%-50.73M

-91.11%-172.05M

-27.53%-40.52M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Aug 31, 2024	(Q2)May 31, 2024	(Q1)Feb 29, 2024	(FY)Nov 30, 2023	(Q4)Nov 30, 2023	(Q3)Aug 31, 2023	(Q2)May 31, 2023	(Q1)Feb 28, 2023	(FY)Nov 30, 2022	(Q4)Nov 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-2.54%-42.18M	-114.98%-39.71M	13.42%-41.95M	49.09%-81.37M	170.32%26.69M	11.18%-41.13M	43.89%-18.47M	-13.66%-48.45M	-89.42%-159.81M	-22.79%-37.96M
Net income from continuing operations	-32.38%-48.96M	-83.49%-44.55M	-1.93%-41.52M	20.19%-143.95M	10.19%-41.96M	19.09%-36.98M	46.53%-24.28M	4.23%-40.73M	-53.90%-180.36M	-23.91%-46.72M
Operating gains losses	----	----	----	6,077.78%556K	--12K	--448K	--40K	--56K	-92.97%9K	--0
Depreciation and amortization	22.52%4.15M	22.74%4.09M	22.26%3.89M	26.33%13.65M	23.71%3.76M	17.26%3.38M	26.63%3.33M	41.15%3.18M	77.70%10.81M	88.63%3.04M
Other non cash items	----	----	----	----	----	----	----	----	--201K	--0
Change In working capital	81.73%-2.7M	-12.04%-5.94M	45.14%-10.21M	205.78%20.12M	3,160.35%58.82M	-40.04%-14.78M	-319.02%-5.3M	-107.72%-18.62M	-308.73%-19.02M	-617.16%-1.92M
-Change in receivables	----	----	----	--0	--2M	----	----	----	354.45%6M	--0
-Change in prepaid assets	-127.93%-570K	-92.11%169K	171.79%1.17M	295.52%2.14M	-136.07%-417K	377.69%2.04M	214,300.00%2.14M	-7.46%-1.63M	79.90%-1.09M	93.31%1.16M
-Change in payables and accrued expense	103.92%7.13M	-49,468.42%-9.38M	140.94%2.66M	-37.42%4.74M	222.28%7.73M	481.06%3.5M	-99.76%19K	-90.15%-6.51M	-3.04%7.57M	-43.51%2.4M
-Change in other current liabilities	9.70%-1.68M	8.31%-1.63M	-11.98%-1.46M	-28.68%-6.27M	-11.41%-1.33M	-64.10%-1.86M	16.73%-1.78M	-219.12%-1.3M	5.31%-4.87M	56.05%-1.19M
-Change in other working capital	53.92%-7.59M	186.47%4.91M	-37.04%-12.59M	173.28%19.51M	1,287.02%50.84M	-77.21%-16.47M	39.81%-5.68M	-153.70%-9.18M	-286.86%-26.63M	-218.87%-4.28M
Cash from discontinued investing activities
Operating cash flow	-2.54%-42.18M	-114.98%-39.71M	13.42%-41.95M	49.09%-81.37M	170.32%26.69M	11.18%-41.13M	43.89%-18.47M	-13.66%-48.45M	-89.42%-159.81M	-22.79%-37.96M
Investing cash flow
Cash flow from continuing investing activities	-193.69%-21.34M	-399.03%-131.07M	121.02%35.51M	151.13%68.3M	-126.13%-14.37M	136.11%22.78M	1,019.85%43.83M	-59.86%16.07M	125.12%27.2M	250.61%55.01M
Net PPE purchase and sale	4.55%-2.35M	-79.35%-1.94M	-26.66%-2.88M	31.39%-8.4M	-0.78%-2.59M	28.06%-2.46M	61.28%-1.08M	34.42%-2.28M	-116.29%-12.24M	-197.56%-2.57M
Net investment purchase and sale	-175.26%-18.99M	-387.53%-129.13M	109.30%38.4M	94.47%76.7M	-120.47%-11.79M	142.30%25.23M	2,372.82%44.91M	-57.83%18.35M	138.45%39.44M	261.45%57.57M
Cash from discontinued investing activities
Investing cash flow	-193.69%-21.34M	-399.03%-131.07M	121.02%35.51M	151.13%68.3M	-126.13%-14.37M	136.11%22.78M	1,019.85%43.83M	-59.86%16.07M	125.12%27.2M	250.61%55.01M
Financing cash flow
Cash flow from continuing financing activities	2,586.03%45.77M	950,908.00%237.75M	9.66%1.62M	-97.25%3.22M	105.19%7K	-98.52%1.7M	-94.21%25K	-0.47%1.48M	-23.84%117.19M	-127.00%-135K
Net common stock issuance	--41.87M	----	----	--0	--0	--0	----	----	-87.08%19.4M	--0
Proceeds from stock option exercised by employees	128.76%3.9M	704.00%201K	9.66%1.62M	-96.71%3.22M	105.19%7K	-98.23%1.7M	-94.21%25K	-0.47%1.48M	2,525.29%97.79M	-127.00%-135K
Cash from discontinued financing activities
Financing cash flow	2,586.03%45.77M	950,908.00%237.75M	9.66%1.62M	-97.25%3.22M	105.19%7K	-98.52%1.7M	-94.21%25K	-0.47%1.48M	-23.84%117.19M	-127.00%-135K
Net cash flow
Beginning cash position	96.61%117.69M	47.12%50.71M	-15.06%55.53M	-19.08%65.38M	-10.84%43.21M	41.06%59.86M	-56.74%34.47M	-19.08%65.38M	-32.41%80.79M	-67.20%48.46M
Current changes in cash	-6.56%-17.75M	163.82%66.98M	84.42%-4.81M	36.13%-9.85M	-27.16%12.32M	-376.51%-16.65M	168.16%25.39M	-2,681.55%-30.9M	60.20%-15.42M	125.28%16.92M
End cash Position	131.33%99.95M	96.61%117.69M	47.12%50.71M	-15.06%55.53M	-15.06%55.53M	-10.84%43.21M	41.06%59.86M	-56.74%34.47M	-19.08%65.38M	-19.08%65.38M
Free cash flow	-2.14%-44.52M	-113.01%-41.64M	11.62%-44.84M	47.83%-89.77M	159.49%24.1M	12.34%-43.59M	45.25%-19.55M	-10.04%-50.73M	-91.11%-172.05M	-27.53%-40.52M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data